CHELSEA WALKER: Open Payments
NPI 1538843792 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 12 payments from 7 companies in 2025. Trend: 2023 $36 · 2024 $38 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $41 |
| ABBVIE INC. | 2 | $32 |
| Amgen Inc. | 2 | $30 |
| Ardelyx, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
Products named: JARDIANCE, OTEZLA, IBSRELA, AUSTEDO XR, QULIPTA, UBRELVY, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
